Quaker Wealth Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
Quaker Wealth Management's ZVRA Position: Q3 2026 in Review
Quaker Wealth Management increased its Zevra Therapeutics (ZVRA) stake by 10% in Q3 2026, buying an estimated $24K and bringing the position to 21,393 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #67.
Quaker Wealth Management first reported a position in ZVRA in Q4 2025 and has held it in 4 quarters since. The position peaked at $278K in Q2 2026. 175 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.
- Quaker Wealth Management held 21,393 shares of Zevra Therapeutics worth $235K as of Q3 2026.
- Quaker Wealth Management bought 2,026 Zevra Therapeutics shares in Q3 2026, an estimated $24K.
- Zevra Therapeutics made up 0.07% of Quaker Wealth Management's portfolio in Q3 2026, its #67 holding.
- Quaker Wealth Management first reported a position in Zevra Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Quaker Wealth Management's Zevra Therapeutics position peaked at $278K in Q2 2026.
- 175 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.
Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.